4 completed, 3 unknown, 1 active not recruiting, 1 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 4, Unknown 3, Active not recruiting 1, Terminated 1 |
Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE Antiplatelet Drug, Warfarin - Antiphospholipid Syndrome, Ischemic Stroke | Phase 4 | Active not recruiting | Seoul National University Hospital | 200 | 2024-02-20 | 2026-09-11 |
| Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window rhTNK-tPA, Antiplatelet Agents - Acute Ischemic Stroke | Phase 4 | Completed | Xuanwu Hospital, Beijing | 570 | 2023-06-02 | 2025-12-02 |
| Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). Coronary angiography, OCT imaging, Percutaneous coronary intervention (PCI): - Myocardial Infarction With Non-Obstructive Coronary Arteries | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 120 | 2021-07-01 | 2024-07-26 |
| Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease Edoxaban Monotherapy, Edoxaban plus Single Antiplatelet Agent - Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Completed | Gi-Byoung Nam | 1040 | 2019-05-14 | 2024-06-10 |
| Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis Oral Anticoagulant, Antiplatelet Drug - Ischemic Stroke, Atrial Fibrillation | Phase 4 | Terminated | National Hospital Organization Osaka National Hospital | 321 | 2017-04-06 | 2024-12-27 |
| The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI Ticagrelor, full amount low molecular weight heparin, half amount low molecular weight heparin - LOVASTATIN/TICAGRELOR [VA Drug Interaction] | Phase 4 | Unknown | Beijing Anzhen Hospital | 300 | 2015-04-01 | 2016-01-20 |
| Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel), Rivaroxaban - Atrial Fibrillation | Phase 4 | Unknown | Japan Cardiovascular Research Foundation | 2200 | 2015-01-01 | 2015-12-30 |
| Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Pioglitazone 15 mg Tablet, Isosorbide Dinitrate 10Mg Tablet, Acetylsalicylic Acid 75Mg Tablet - Adverse Effect, Atherosclerosis, Coronary | Phase 4 | Completed | Ukrainian Medical Stomatological Academy | 43 | 2012-11-01 | 2022-03-10 |
| Reducing Total Cardiovascular Risk in an Urban Community Lifestyle Changes, Antiplatelet Agents, Beta Blocker - Cardiovascular Diseases, Heart Diseases | Phase 4 | Completed | Johns Hopkins University | 525 | 2006-05-01 | 2017-09-15 |
Atrial Fibrillation (3) · Ischemic Stroke (3) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Coronary Artery Disease (2) · Coronary Disease (2) · Thrombosis (2) · Angina Pectoris, Variant (1) · Angina, Stable (1) · Antiphospholipid Syndrome (1) · Cerebrovascular Disorders (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Hypertension (1) · Insulin Resistance (1)
Beijing Anzhen Hospital (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Gi-Byoung Nam (1) · Japan Cardiovascular Research Foundation (1) · Johns Hopkins University (1) · National Hospital Organization Osaka National Hospital (1) · Seoul National University Hospital (1) · Ukrainian Medical Stomatological Academy (1) · Xuanwu Hospital, Beijing (1)
China (2) · Japan (2) · South Korea (2) · Italy (1) · Ukraine (1) · United States (1)
Duk-woo Park, MD (1) · Hiroshi Yamagami, MD (1) · Hisao Ogawa (1) · Jerilyn Allen (1) · Junwei Hao, MD (1) · Nicola Cosentino, MD (1) · Qingfeng Ma, MD (1) · Riccardo Gorla, MD (1) · Seung-Hoon Lee, MD, PhD (1)
PMID 21953407, PMID 31475793, PMID 33657403, PMID 34261738, PMID 34474583, PMID 34658247, PMID 34736731, PMID 35209924, PMID 35697255, PMID 35704345, PMID 35734824, PMID 36713761, PMID 37173099, PMID 37815031, PMID 39225258, PMID 39539664, PMID 40802193, PMID 40930594, PMID 41051787, PMID 41308951, PMID 41642827, PMID 41762182, PMID 41848064, PMID 42003300, PMID 42690164
R01HL082638 (1)